{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21021 Viral Haemorrhagic Fever (VHF) Policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "VIRAL HAEMORRHAGIC FEVER (VHF) POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21021"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "28 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "27 April 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Viral Haemorrhagic Fever"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "WHO Guidance & Health protection Agency, London. Information pages for VHF."
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Head of Infection Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Infection Control Committee Southend Infection Control Committee Basildon Infection Control Committee Broomfield"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience"
                    },
                    {
                        "text": "Director Harm Free Care"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "27 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "May 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21021 Viral Haemorrhagic Fever (VHF) Policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Edith Mahachi"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control Basildon"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Judy Holdsworth"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control Broomfield"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Dr Awad-El-Kariem"
                    },
                    {
                        "text": "Consultant Microbiologist /DIPC Basildon"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Dr Javeed Ahmed"
                    },
                    {
                        "text": "Consultant Microbiologist/Virologist Southend"
                    },
                    {
                        "text": "12 April 2021"
                    },
                    {
                        "text": "Dr John Day"
                    },
                    {
                        "text": "Consultant Infectious Disease/Infection Control Doctor Southend"
                    },
                    {
                        "text": "03 April 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Trust IPCC"
                    },
                    {
                        "text": "12 April 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Isolation Policy Standard Precautions Policy for Hand Decontamination Medical Equipment Decontamination Policy Management of Spillage of Biological Fluids Prevention of Sharps Injury Management of Outbreaks Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "New MSE Policy Supersedes IC031 CP/PG/00139"
                    },
                    {
                        "text": "28 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 8"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Diagnosis ...................................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Infectivity ....................................................................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Risk Assessment .......................................................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Minimum risk category .................................................................................................. 9"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Moderate risk category ................................................................................................. 9  High risk category ....................................................................................................... 10  Management of patients categorised as \u2018VHF unlikely' .............................................. 10  Management of patients categorised as \u2018possible VHF' ............................................. 10  Infection Control Measures: ........................................................................................ 11  Personal Protective Equipment................................................................................... 11  Laundry /linen ............................................................................................................. 11  Clinical waste .............................................................................................................. 11  Clinical samples .......................................................................................................... 11  Duration ...................................................................................................................... 11  Clinical Management .................................................................................................. 12  Infection Control Measures: ........................................................................................ 12  Cleaning and Decontamination ................................................................................... 14  Communications ......................................................................................................... 14  Incident Meeting ......................................................................................................... 15  Training Requirements ............................................................................................... 15  Monitoring and Audit ................................................................................................... 15 Approval and Implementation ..................................................................................... 15  Equality Impact Assessment ....................................................................................... 16  References ................................................................................................................. 16 Appendix 1: Preliminary Equality Analysis ......................................................................... 17"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Viral haemorrhagic fevers (VHFs) are severe and life-threatening diseases caused by a range of viruses. VHFs are endemic in parts of Africa, South America, the Middle East and Eastern Europe."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "If a patient is suspected, following risk assessment, to be \u201cLow Possibility of VHF\u201d, \u201cHigh Possibility of VHF\u201d or confirmed as having a VHF, the Infection Prevention & Control Team and Consultant Microbiologist , if out-of-hours, the Consultant Microbiologist on-call) must be informed by the medical team looking after the patient immediately for discussion of appropriate Infection Prevention & Control measures. Other relatively common causes of febrile illness in travellers returning from Africa or other high risk countries include typhoid fever, dengue, Rickettsial infections, malaria and other tropical parasites. Multiple infections are not uncommon in the tropics and the finding of malarial parasites does not absolutely exclude one of the haemorrhagic fevers or other serious infections. As considered appropriate, the Consultant Microbiologist will discuss the case with either the Royal Free Infectious Diseases team and/or the Special Pathogens Reference Unit (SPRU) at the Public Health England (PHE) Centre for Emergency Preparedness and Response at Porton Down, together with notifying the local PHE Health Protection Unit (HPU) team."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The following websites contain information related to VHFs and updates on current cases and outbreaks of infectious disease including VHFs and can be used as an aid to risk assessment:"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ViralHaemorrhagicFe ver"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "text": "http://www.healthmap.org/promed/"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.4,
                "text": "Important contact numbers"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consultant Microbiologist \u2013 contact via switchboard"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Free Hospital (HSIDU) - Tel: 0207 7940500 (Ask for: Infectious Disease Doctor on-call)"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "High Security Infectious Disease Viral Diagnostic Laboratory - Tel: 0208 2004400"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "VHFs are caused by a diverse group of Viruses which can cause an array of illnesses from relatively mild to severe and life threatening. Humans are not the natural hosts of the viruses but they become infected after contact with an infected host reservoir, e.g. rodents or arthropod vectors. Transmission between humans is also possible and is the main risk of importing the viruses to different areas or countries where infection by natural host is unlikely."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.6,
                "text": "VHFs are of particular public health importance because:"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "They can spread readily within a hospital setting."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "They have a high case-fatality rate."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "They are difficult to recognise and detect rapidly."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is no effective treatment."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.7,
                "text": "The table below indicates those VHFs that are caused by pathogens classified by the Advisory Committee on Dangerous Pathogens (ACDP) as Hazard Group 4"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Arenaviridae Bunyaviridae"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Old World arenaviruses"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Nairoviruses"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Lassa"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Crimean Congo haemorrhagic fever"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Lujo"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.8,
                "text": "The main routes of transmission are:"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Direct contact through broken skin or mucous membrane with blood or body fluids."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Indirect contact with environments contaminated with splashes or droplets of blood or body fluids."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.9,
                "text": "Geographical Distribution"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "1.9.1 VHFs are severe and life-threatening viral diseases that are endemic in parts of Africa, South America, the Middle East and Eastern Europe. All recorded cases of VHF in the UK have been acquired abroad, with one exception of a laboratory worker who sustained a needle-stick injury. There have to date been no cases of person-to-person transmission within the UK."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "1.9.2 VHF diagnosis is based on having visited an area in Table 1 within  days of developing symptoms listed in Table"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "1.9.3 Table 1"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "type": "table",
            "sequence_num": 48,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Risk Area"
                    },
                    {
                        "text": "Typical Infections"
                    },
                    {
                        "text": "Comments"
                    },
                    {
                        "text": "West and Central Africa, especially Guinea, Liberia, Sierra Leone and Nigeria"
                    },
                    {
                        "text": "Lassa Fever"
                    },
                    {
                        "text": "Accounts for all UK cases to date"
                    },
                    {
                        "text": "East Africa and as above"
                    },
                    {
                        "text": "Crimea Congo Fever, Ebola, Marburg"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Southern Africa"
                    },
                    {
                        "text": "Lujo"
                    },
                    {
                        "text": "Hospital outbreak in 2008"
                    },
                    {
                        "text": "North Eastern Bolivia (Benji) Central Venezuela, Argentine papas, Eastern Europe and the Balkans"
                    },
                    {
                        "text": "New World Haemorrhagic Fevers Haemorrhagic Fever with Renal Syndrome"
                    },
                    {
                        "text": "Sporadic and rare"
                    },
                    {
                        "text": "The Middle East and as above"
                    },
                    {
                        "text": "Crimea Congo Fever"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.1,
                "text": "This  policy  describes  when  to  consider  VHF,  the  procedure  for  transfer  to  a specialist unit and the precautions to follow in such circumstances. It is based on international guidance and in particular the outcome of the UK- wide review of VHF management by the Advisory Committee on Dangerous Pathogens."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "type": "table",
            "sequence_num": 52,
            "data": {
                "num_rows": 13,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "AST"
                    },
                    {
                        "text": "Aspartate aminotransferase test."
                    },
                    {
                        "text": "Category A infectious waste"
                    },
                    {
                        "text": "Waste that is known or suspected to be contaminated with pathogens presenting the most severe risk."
                    },
                    {
                        "text": "Ebola and Marburg Virus"
                    },
                    {
                        "text": "These are members of the filovirus family. These two viruses cause the most severe forms of haemorrhagic fever. The first outbreak of Marburg disease was in a number of laboratory workers in Marburg (Yugoslavia) and Frankfurt, (Germany). The first known cases of Ebola occurred in 1976 in Zaire and Sudan. Since March 2014, West Africa has experienced the largest outbreak of Ebola in history, with multiple countries affected(https://www.cdc.gov/vhf/ebola/outbreaks/2014-west -"
                    },
                    {
                        "text": "africa/distribution-map.html)."
                    },
                    {
                        "text": "Lassa Fever"
                    },
                    {
                        "text": "Acute VHF which is caused by the Lassa virus, a member of the arenavirus. The disease was first described in the 1950's and was identified in 1969 when two missionary nurses died from it in the town of Lassa in Nigeria"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director Infection Prevention and Control"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South Essex Trust"
                    },
                    {
                        "text": "Standard precautions"
                    },
                    {
                        "text": "The basic protective actions taken by healthcare workers in the care of all patients. They prevent/ minimise contact of intact / non-intact skin and mucous membranes with blood / body fluids, and prevent sharps injuries"
                    },
                    {
                        "text": "Category B infectious waste"
                    },
                    {
                        "text": "Waste that is known or suspected to be contaminated with pathogens not listed in inclusion Category A waste"
                    },
                    {
                        "text": "Viral Haemorrhagic Fevers (VHF)"
                    },
                    {
                        "text": "A group of illnesses that are caused by several distinct families of viruses: arenaviruses, filoviruses, bunyaviruses and flaviviruses. Some of these cause relatively mild illnesses, whilst others can cause severe, life-threatening disease."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Infection Prevention and Control Site Committee's (IPCC's) is responsible for the review of this policy at least every two years, but more frequently if there are changes to Infection Prevention and Control Legislation or guidance."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The Chief Executive has overall responsibility for ensuring that the Trust has the necessary management systems in place to enable the effective implementation of this policy and overall responsibility for the health and safety of staff, patients and visitors"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Director for Infection Prevention and Control (DIPC) will have operational responsibly for the effective implementation of this policy"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The Infection Prevention and Control Team (IPCT) are responsible for ensuring all staff are made aware of this policy, advising ward staff on control measures, and providing them with the necessary advice"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "All Staff must comply with this policy and act in a responsible manner, liaising with the IPCT in a timely manner if in need of advice or support. All staff have a responsibility to ensure that infection prevention and control is embedded into their everyday practice and applied consistently at all times"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Diagnosis"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "In the early stages of the illness there may be no specific clinical features and so the diagnosis must be considered in anyone who develops an unexplained fever within three weeks of returning from the areas listed in the introduction."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "The following information should be established from the patient:"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Countries and towns visited."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The purpose of the visit."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Did the visit involve visiting rural areas?"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Did the patient have contact with illness consistent with VHF?"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Did the patient have contact with rats or other rodents?"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Did the patient eat bush meat or import any into the country?"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Did the patient take anti-malarials regularly? If yes obtain details."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of return to the UK."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of onset of illness."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Details of illness"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Clinical features may include: fever, headache, myalgia, pharyngitis, diarrhoea, bloody diarrhoea, vomiting, rash, bleeding, shock, lymphopaenia, thrombocytopaenia and raised AST."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Infectivity"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Dependant on the virus, modes of transmission can include blood, urine, semen, vomit, faeces, tick bites. There has been no evidence of aerosol transmission from VHF patients. If there is no immediate threat to life (malaria being excluded), patients may remain at home. Patients can be managed more effectively if they are categorised according to level of infectivity and risk."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Risk Assessment"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "The Consultant Microbiologist /Virologist should be notified as soon as possible and preferably before the patient is admitted to assess the level of risk and determine whether admission locally is appropriate."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Minimum risk category"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Includes febrile patients who have a history of foreign travel but have not been to an endemic area , or"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.0,
                "text": "Patients who have been in endemic areas or have been in contact with a known or suspected source of VHF, but in whom the onset of illness occurred more than  days after contact."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Moderate risk category"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.0,
                "text": "Includes febrile patients that have been in an endemic area during the  days before the onset of illness, but have none of the additional risk factors that place them in the high risk category, or"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.0,
                "text": "Patients who have not been in a known endemic area but who may have been in adjacent areas or countries during the  days before the onset of illness, and who have evidence of severe illness with organ failure and/or haemorrhage which could be due to VHF, and for which no alternative diagnosis is currently evident."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "High risk category"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.0,
                "text": "Includes febrile patients who have been in an endemic area within  days before illness and:"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Have household contact for more than four hours with people who are known or suspected of having a VHF or"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Nursed or cared for patients known or suspected of having a VHF or"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Are a laboratory worker who has had contact with body fluids or tissues of a human or animal known or strongly suspected of having VHF or"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Were previously categorised as \u2018moderate' risk, but who have developed organ failure and/or haemorrhage."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Patients who  have not been in an endemic area  will also be considered a high risk if they cared for a patient or animal known or strongly suspected of having a VHF, or came into contact with their bodily fluids or tissue  days preceding illness, or"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Handled clinical specimens known or strongly suspected to contain a VHF virus"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Please click on link below for latest guidance:"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/4781 15/VHF_Algo.pdf"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Management of patients categorised as \u2018VHF unlikely'"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Manage using standard infection control precautions. If the patient develops bleeding, sudden fall in platelets or a rise in AST, shock or unexplained rise in O2 requirement then reconsider the categorisation."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "As per guidance link"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Management of patients categorised as \u2018possible VHF'"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "As per guidance link"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Discuss with the Royal Free Infectious Disease Unit London. This patient should be transferred to the High Security Infectious Disease Unit as a priority. They can be contacted 24 hours a day on 0207 794 0500 or 0844 848 0700."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Infection Control Measures:"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.1,
                "text": "Isolation"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.1.1  The patient should be isolated in a single side room. This should be in the Emergency Department."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Personal Protective Equipment"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Details are given in the National Guidance and should be discussed with detail by the Infection Prevention and Control Department. If the patient has bleeding, bruising, diarrhoea, vomiting or cough then: gloves, apron, face mask, visors are recommended. If aerosol or splash generating procedures are undertaken then a FFP3 mask is also required. Otherwise normal standard precautions are sufficient."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Laundry /linen"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Linen should be disposed of as contaminated waste. This should be placed in an orange clinical waste bag."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Clinical waste"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "This should be disposed of as Category B clinical waste following the normal procedures described in the waste policy."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Clinical samples"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Patient will require an urgent malaria investigation."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "When dealing with blood and other body fluids and tissue samples, no special precautions are required (refer to national guidance). Clinical waste generated by taking the samples, or in the lab, should be treated as clinical waste as normal. Sample can be analysed in closed analysers with category 2 precautions."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Duration"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "Precautions should continue until a firm alternative diagnosis is made or the patient is well."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Clinical Management"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "Most possible VHF cases have another condition, usually an infection such as malaria."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "The possible VHF should not delay the full investigation and management of other infections."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.3,
                "text": "Management of patients Categorised as \u2018high possibility of VHF'"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.3.1 As per guidance link"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.3.2 Management should be led by a senior clinician and fully involve the Direction of Infection Prevention and Control and or the Consultant Microbiologist and the Infection Prevention and Control Team. The aim of management is to prepare the patient for transfer to the High Security Infectious Disease Unit while protecting other patients and staff."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.4,
                "text": "The patient will require an urgent malaria investigation, then:"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Discuss with Infection Consultant (Infectious Disease/Microbiology/Virology)"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Infection Consultant to arrange VHF screen with Imported Fever Service (0844 7788990)"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Notify Local Health Protection Unit"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consider empiric antimicrobials"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Infection Control Measures:"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.1,
                "text": "Isolation"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.1 The patient should be isolated as described in the isolation Policy. This should be in the Emergency Department .The patient must use a dedicated commode, not en- suite facilities"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.2,
                "text": "Personal Protective Equipment"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.2.1  Details are given in the national guidance and will be discussed in detail by the Duty Infection Control staff. If the patient has bleeding, bruising, diarrhoea, vomiting or cough then: double gloves, fluid repellent disposable gown, visor, FFP3 mask. Where none of these symptoms are present gloves, apron, surgical face mask and visor are recommended. If aerosol or splash generating procedures are undertaken then an FFP3 mask would be required."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.3,
                "text": "Laundry"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.3.1  Laundry should be disposed of as contaminated waste. Visibly soiled laundry should be disposed of as clinical waste."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.4,
                "text": "Clinical waste"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.4.1  This should be disposed of as Category A clinical waste. Arrangements will be made through the Infection Control Team and Waste Manager. This waste will be disposed by specialist contractor."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.5,
                "text": "Clinical samples"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.5.1 Clinical samples e.g. blood and other body fluids and tissue samples. Samples should be kept to a minimum and discussed with the relevant lab prior to being sent. Samples should be transported in a suitable sealed container."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 1,
                "text": "20.5.2 Samples MUST NOT be sent via the pneumatic transport system."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.5.3 Gloves and an apron should be worn when handling or transporting such samples. In the laboratory a visor should also be worn. Clinical waste generated by taking the samples to, or in the lab, should be treated as category A clinical waste. Samples should be decontaminated where possible prior to analysis. The National Guidance provides details of the precautions for laboratory procedures."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.6,
                "text": "Duration"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.6.1  Precautions should continue until the patient is well/ transferred to the High Security Infectious Disease Unit."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.7,
                "text": "Clinical Management"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.7.1 An urgent VHF screen (EDTA and a serology sample) should be sent to the HPA reference laboratory. Contact details in section 7.35 and in the National Guidance. The reference lab should be informed that the samples are to be sent and will discuss transport arrangements."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.7.2 Results should be available within 6 hours of receipt."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.7.3 If the results are negative the patient should be managed as \u2018possible VHF' as in 4 above."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.8,
                "text": "Management of Patents Categorised as having VHF"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.8.1  Details of management of confirmed VHF are described in the National Guidance and will not be undertaken at any of the MSE sites"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.9,
                "text": "Transfer to the High Security Infectious Disease Unit"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.9.1 This should be undertaken when a patient is categorised as \u2018possible' VHF and requires transfer to the High Security ID Unit or as \u2018possible VHF'."
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.9.2 The patient should be transferred wearing a surgical face mask"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.9.3 Staff should wear the PPE as appropriate to the patient's risk stratification"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.9.4 Transfer should be as direct and prompt as possible. Staff should be designated to call and keep a lift and ensure visitors and other staff maintain a safe distance (for practical purposes at least one and ideally two meters)."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.9.5 Transfer can only be undertaken in an ambulance category 4 vehicle. The London Ambulance Service will make the necessary arrangements and should be contacted as soon as VHF is suspected to avoid delays."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Cleaning and Decontamination"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.1,
                "text": "This is described in detail in the national guidance. In brief:"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "Cleaning should:"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be undertaken promptly"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be undertaken using PPE appropriate to the risk classification of the patient"
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Areas requiring such cleaning should be identified promptly and discussed with the IPCT"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Decontamination of visible spills of body fluid should be undertaken as described in the Management of Blood and Other Body Fluid Spillages policy"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cleaning should use 1,000ppm free chlorine."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.3,
                "text": "Commodes should be considered as of particular infection risk."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.4,
                "text": "These should be cleaned with 1000ppm available chlorine after each use and on patient discharge. The ICT will ensure the availability of a suitable product."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Communications"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "Clinical staff suspecting VHF should immediately discuss the case with the Consultant Microbiologist and Infectious Disease Consultant. The Consultant responsible for the patient or on call Consultant should then be contacted, and be fully involved in all subsequent discussions. Either the Consultant responsible or the Consultant Microbiologist should then contact the High Security ID Unit who are available 24 hours on 0207 794 0500 or 0844 848 0700"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "The Duty Microbiologist will also contact other appropriate members of the Infection Control Team to ensure enough support is being provided including, the Hospital Duty Manager, Clinical Site Manager and Public Health."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Incident Meeting"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "It is expected that most patients will stay only a short time in the Emergency Department prior to transfer. A debrief Incident Meeting attended by those involved should be arranged as soon as possible. It should address whether all precautions were in place and whether all potential risk has been"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "All Trust staff to undertake Mandatory Infection Prevention and Control updates and Donning and Doffing updates."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "The IPCT has primary responsibility for providing training on the policy where needed. Managers have the responsibly to support the IPCT by ensuring that staff are able to attend training sessions in response to identified needs"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "type": "table",
            "sequence_num": 171,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectivenes s being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group/Committee/forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee/indivi dual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Understandin g and compliance with Policy"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "On a case by case basis"
                    },
                    {
                        "text": "Infection Prevention and Control Committee"
                    },
                    {
                        "text": "Infection Prevention and Control Matron/ADIPC"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "All policies, procedures and guidelines will be approved by the Infection Prevention and Control Committee, which is the specialist group with the authority to approve the MSE Policy. These will then be forwarded to the Document control team for submission and ratification by the Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.2,
                "text": "It is the author's responsibility to inform the Director of Harm Free Care of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 1,
                "text": "https://www.gov.uk/government/publications/viral-haemorrhagic-fever-algorithm- and-guidance-on-management-of-patients"
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This is the primary source for clinical VHF issues in the UK. It must be consulted when managing a suspected case ."
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health Technical Memorandum 07-01: Safe Management of Healthcare Waste. Department of Health 2006."
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "European Directive 89/686/EEC. European Commission 1989"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Centre for Disease Control, Atlanta, US. Information pages for VHF. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm"
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health protection Agency, London. Information pages for VHF."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ViralHaemorrhagic Fever/"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Viral Haemorrhagic Fever (VHF) Policy / MSEPO-21021/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Viral Haemorrhagic Fever (VHF) Policy / MSEPO-21021/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix1: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Viral Haemorrhagic Fever (VHF) Policy / MSEPO-21021: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "type": "table",
            "sequence_num": 191,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 192,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Standardise existing site policy's"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "One MSE VHF Policy"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 193,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head of Infection Control MSE"
                    },
                    {
                        "text": "22 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 195
        }
    ]
}